0001062993-23-010091.txt : 20230503 0001062993-23-010091.hdr.sgml : 20230503 20230503162046 ACCESSION NUMBER: 0001062993-23-010091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230501 FILED AS OF DATE: 20230503 DATE AS OF CHANGE: 20230503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Doyle John Brendan CENTRAL INDEX KEY: 0001840738 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40886 FILM NUMBER: 23884323 MAIL ADDRESS: STREET 1: C/O CHIASMA INC. STREET 2: 140 KENDRICK STREET BUILDING C EAST CITY: NEEDHAM STATE: MA ZIP: 20494 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COGNITION THERAPEUTICS INC CENTRAL INDEX KEY: 0001455365 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2403 SIDNEY STREET STREET 2: SUITE 261 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: 412-481-2210 MAIL ADDRESS: STREET 1: 2500 WESTCHESTER AVE CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: COGNITION THERAPUTICS INC DATE OF NAME CHANGE: 20090204 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0407 4 2023-05-01 0001455365 COGNITION THERAPEUTICS INC CGTX 0001840738 Doyle John Brendan C/O COGNITION THERAPEUTICS, INC. 2500 WESTCHESTER AVE PURCHASE NY 10577 0 1 0 0 Chief Financial Officer 0 Common Stock 2023-05-01 4 A 0 109824 0.00 A 109824 D Stock Option (right to buy) 1.65 2023-05-01 4 A 0 109824 0.00 A 2033-05-01 Common Stock 109824 109824 D Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The option vests 25% on May 1, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates. /s/ Lisa Ricciardi, Attorney-in-Fact 2023-05-03